Artery

Business

ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM By Investing.com

NAPERVILLE, Ill., Sept. 28, 2024 /PRNewswire/ — Endotronix, an Edwards Lifesciences company (NYSE: EW), today announced the one-year clinical results…

Read More »
Science

Solving the riddle of the sphingolipids in coronary artery disease

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of…

Read More »
Back to top button